Revalesio is a clinical-stage pharmaceutical company with a vision to develop safe and effective treatments for people with neurological diseases. Our pioneering science and nanotechnology address fundamental disease mechanisms, such as mitochondrial dysfunction and inflammation, to provide neuroprotection and thereby slow disease progression and improve quality of life.